MARKET INTRODUCTION

As per the Anxiety and Depression of America, approximately 322 million people are living with depression worldwide. Anxiety disorders are the most common mental disorders. However, they are treatable, and a number of treatments are available to help patients. Anxiety and depression are different conditions but mostly coexist. Nearly 50% of the population diagnosed with depression is also diagnosed with anxiety. These disorders cause people to avoid situations and trigger panic attacks.

MARKET DYNAMICS

The anxiety disorders and depression treatment market is anticipated to grow in the forecast period owing to the increasing prevalence of anxiety disorders and depression globally. Currently, developed countries are grappling with mental illnesses hugely. For instance, in the U.S., around 10 million people suffer from mental illness every year. This can be attributed to the increasing anxious millennial population in the region. Apart from this, increasing awareness and the growing contribution of government organizations to ease disease burden are further boosting the growth of the market. Some of the prominent organizations working in this space are the Hope for Depression, the National Alliance on Mental Illness, and the American Psychiatric Association, among others. In addition, an increase in research and development activities are opening new growth avenues for the market.

- For instance, in 2019, Johnson & Johnson received approval for its ketamine-based depression treatment
- Another notable advancement was the approval of first postpartum depression drug brexanolone by Sage Therapeutics in March 2019

MARKET SCOPE

The "Global Anxiety Disorders and Depression Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of anxiety disorders and depression treatment market with detailed market segmentation by drug type, therapies, devices, application, end user and geography. The global anxiety disorders and depression treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anxiety disorders and depression treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global anxiety disorders and depression treatment market is segmented on the basis of drug class, therapies, devices, application and end users. Based on drug class, the market is segmented as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), antidepressant drugs, atypical antipsychotics, benzodiazepines, beta-blockers. Based on therapies, the market is segmented as electroconvulsive therapy (ECT), psychotherapy, deep brain stimulation, cognitive behavior therapy (CBT), cranial electrotherapy stimulation (CES), trans cranial magnetic stimulation (TMS). Based on devices, the market is segmented as cranial electrotherapy stimulator and fisher-wallace stimulator market. Based on application, the market is segmented into phobia, obsessive compulsive disorder (OCD), post-traumatic stress disorder, major depressive disorder and others. Based on end user, the market is segmented into hospitals, mental healthcare centers and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anxiety disorders and depression treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anxiety disorders and depression treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anxiety disorders and depression treatment market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anxiety disorders and depression treatment market in these regions.

MARKET PLAYERS

The report covers key developments in the anxiety disorders and depression treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anxiety disorders and depression treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for anxiety disorders and depression treatment market in the global market. Below mentioned is the list of few companies engaged in the anxiety disorders and depression treatment market.

The report also includes the profiles of key anxiety disorders and depression treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Sumitomo Dainippon Pharma Co.
- Sage Therapeutics
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Abbott
- Sanofi
- H. Lundbeck A/S
- Johnson & Johnson

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.